[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-357526-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-357526-en":131},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","sopa-and-simpa-normalized-single-sample-integrated-multiomics-pathway-analysis-of-tumor-heterogeneity-in-solid-cancers","SOPA and SIMPA - normalized single-sample integrated multiomics pathway analysis of tumor heterogeneity in solid cancers","","Inter-sample tumor heterogeneity poses significant challenges to metastatic cancer treatment. Although multiomics analyses provide nuanced molecular insights, many pathway tools rely on group-based comparisons that can miss differential, single-sample perturbations. This work introduces SOPA for normalized single-sample, single-omic pathway analysis and extends it to SIMPA for supervised differential pathway activity using predefined controls. Results show SOPA outperforms standard single-sample methods, while SIMPA captures immune and metabolic dysregulation and survival differences overlooked by unsupervised alternatives. A freely available Python package supports preclinical and clinical research.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/sopa-and-simpa-normalized-single-sample-integrated-multiomics-pathway-analysis-of-tumor-heterogeneity-in-solid-cancers/357526/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/sopa-and-simpa-normalized-single-sample-integrated-multiomics-pathway-analysis-of-tumor-heterogeneity-in-solid-cancers/357526.png","ImageObject",300,407,{"name":42,"@type":43},"Anna Hans","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",12,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What problem do SOPA and SIMPA address in multiomics pathway analysis?","Question",{"text":63,"@type":64},"They address the limitation of existing pathway tools that primarily perform group-based comparisons and can overlook differential perturbations present in individual tumor samples.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"How does SOPA differ from SIMPA?",{"text":68,"@type":64},"SOPA performs normalized single-sample single-omic pathway analysis, while SIMPA extends this idea to supervised normalized single-sample integrated multiomics pathway analysis across multiple omics layers.",{"name":70,"@type":61,"acceptedAnswer":71},"What advantages do SOPA and SIMPA show compared with existing methods?",{"text":72,"@type":64},"SOPA shows advantages over standard single-sample approaches for detecting deviations from predefined controls, and SIMPA provides effective alternatives to unsupervised tools by identifying dysregulated immune and metabolic pathway activity, including tumor subgroups with survival differences.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},357526,1790374954,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,120,123,127],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":116,"doc_module":4,"doc_module_name":25,"category_name":117,"show_sort_weight":118,"slug":119},9,"Religion & Spirituality",20,"religion-spirituality",{"id":118,"doc_module":4,"doc_module_name":25,"category_name":121,"show_sort_weight":118,"slug":122},"World Cup","world-cup",{"id":124,"doc_module":4,"doc_module_name":25,"category_name":125,"show_sort_weight":124,"slug":126},10,"Lifestyle","lifestyle",{"id":128,"doc_module":4,"doc_module_name":25,"category_name":129,"show_sort_weight":97,"slug":130},19,"General","general",{"code":4,"msg":82,"data":132},{"doc_id":79,"user_id":133,"nickname":42,"user_avatar":134,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":135,"file_id":136,"file_url":137,"file_type":138,"file_size":139,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":140,"language":141,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":142,"faqs":143,"seo_title":144,"seo_description":12,"update_tm":145,"read_time":146,"preview_page_count":33,"preview_urls":147},5909892332657,"https://ap-avatar.wpscdn.com/davatar_994ba38a5ba835b3df7d355c54d3ed8d","Brieﬁngs in Bioinformatics, 2026, 27, bbag338 [https://doi.org/10.1093/bib/bbag338](https://doi.org/10.1093/bib/bbag338)  \n[Published: 8 July 2026](Published: 8 July 2026)  \nProblem Solving Protocol  \nSOPA and SIMPA: normalized single-sample integrated multiomics pathway analysis of tumor heterogeneity in solid cancers  \nHasan Alsharoh1 , 2 , Abdulrahman Ismaiel 3 , George A. Calin 4 , 5 , 6 , Ovidiu L. Pop 7 , Ioana Berindan-Neagoe 2 , 8 , 9 , *,  \nAndreas Bender 2 , 10 , 11 , 12  \n1 Doctoral School of Biomedical Sciences, Faculty of Medicine and Pharmacy, University of Oradea, Str. Universitatii Nr.1, 410087 Oradea, Romania  \n2 Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Haieganu University of Medicine and Pharmacy, Str. Gh. Marinescu Nr.23, 400337 Cluj-Napoca, Romania  \n3 2nd Department of Internal Medicine, Iuliu Haieganu University of Medicine and Pharmacy, Str. Clinicilor 3-5, 400006 Cluj-Napoca, Romania  \n4 Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Boulevard, Unit 422, Houston, TX 77030, United States  \n5 Translational Molecular Pathology, MD Anderson Cancer Center, Texas State University, 1515 Holcombe Blvd, Houston, TX 77030, United States  \n6The RNA Interference and Non-coding RNA Center, MD Anderson Cancer Center, Texas State University, 1515 Holcombe Blvd, Houston, TX 77030, United States  \n7 Faculty of Medicine and Pharmacy, University of Oradea, P-ta 1 December 10, 410073 Oradea, Romania  \n8 Doctoral School, Iuliu Hatieganu University of Medicine and Pharmacy, Victor Babes Nr.8, 400012 Cluj-Napoca, Romania  \n9Academy of Medical Sciences, Bulevardul I.C. Braitanu Nr.1, Sector 3, 030171 Bucharest, Romania  \n10 Department of Medicine and Center for Biotechnology, College of Medicine and Health Sciences, Khalifa University of Science and Technology, Abu Dhabi, Shakhbout Bin Sultan Street, Hadbat Al Za’faranah, Zone 1, 12778, United Arab Emirates  \n11 STAR-UBB Institute, Babes¸ -Bolyai University, Str. Mihail Koglniceanu Nr.1, 400084 Cluj-Napoca, Romania  \n12 Centre for Molecular Informatics, Department of Chemistry, University of Cambridge, Lensﬁeld Road, Cambridge CB2 1EW, United Kingdom  \n*Corresponding author. Department of Genomics, MEDFUTURE Institute for Biomedical Research, Iuliu Ha¸tieganu University of Medicine and Pharmacy, Str. Gh. Marinescu Nr.23, 400337 Cluj-Napoca, Romania. E-mail: [ioana.neagoe@umfcluj.ro](ioana.neagoe@umfcluj.ro)  \n| • • •\u003Cbr>Abstract\u003Cbr>Inter-sample tumor heterogeneity poses significant challenges to metastatic cancer treatment. Although multiomics analyses provide nuanced molecular insights into tumor heterogeneity, current molecular pathway analysis tools focus on group-based comparisons, which may overlook differential single-sample perturbations. Here, we present normalized single-sample single-omic pathway analysis (SOPA), and its extension, normalized single-sample integrated multiomics pathway analysis (SIMPA), as a bioinformatics pipeline for performing supervised differential pathway analysis. The pipeline utilizes custom algorithms to analyze differential pathway activity in single samples, comparing the molecular profile in each sample to a range of controls. In single-omics analysis, SOPA shows advantages compared to standard tools such as single sample gene set enrichment analysis and gene set variation analysis in identifying single sample deviations from predefined controls. For integrated multiomics, we show that in predefined-control contexts, SIMPA provides an effective alternative over unsupervised tools such as multiomics gene set analysis (MOGSA) and PAthway Deviation scores using Multiple Factor Analysis (padma), addressing tumor heterogeneity. Particularly, SIMPA unveiled particular tumor subgroups with dysregulated immune and metabolic pathway activity marked by variable immune infiltration and survival differences, which were missed by MOGSA and padma. Overall, SOPA and SIMPA ","cbCaiiw1OgsPwJAf","https://ap.wps.com/l/cbCaiiw1OgsPwJAf","pdf",1799235,14,"English","# Abstract\n# Introduction\n## Problem: inter-sample heterogeneity and limitations of group-based pathway tools\n## Proposed solution: SOPA and SIMPA normalized approaches for supervised single-sample pathway activity","[{\"question\":\"What problem do SOPA and SIMPA address in multiomics pathway analysis?\",\"answer\":\"They address the limitation of existing pathway tools that primarily perform group-based comparisons and can overlook differential perturbations present in individual tumor samples.\"},{\"question\":\"How does SOPA differ from SIMPA?\",\"answer\":\"SOPA performs normalized single-sample single-omic pathway analysis, while SIMPA extends this idea to supervised normalized single-sample integrated multiomics pathway analysis across multiple omics layers.\"},{\"question\":\"What advantages do SOPA and SIMPA show compared with existing methods?\",\"answer\":\"SOPA shows advantages over standard single-sample approaches for detecting deviations from predefined controls, and SIMPA provides effective alternatives to unsupervised tools by identifying dysregulated immune and metabolic pathway activity, including tumor subgroups with survival differences.\"}]","SOPA and SIMPA - normalized single-sample integrated multiomics pathway analysis of tumor heterogeneity in solid cancers | PDF",1790130269,35,[148,152,156,160],{"page_no":22,"url":149,"width":150,"height":151},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/bafe0e07ad3b7230c8b02e38f6030ca2.webp",983,1291,{"page_no":26,"url":153,"width":154,"height":155},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8953975c9622cd9b73f025f29ccbd926.webp",982,1290,{"page_no":30,"url":157,"width":158,"height":159},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dd0aa537fbe71d71517c0709ca12bb6d.webp",981,1289,{"page_no":33,"url":161,"width":162,"height":163},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9f0911f4abd3c7a5d21467db00eb1ce6.webp",980,1287]